APA

Doria A., Stohl W., Schwarting A., Okada M., Scheinberg M., van Vollenhoven R., Hammer A. E., Groark J., Bass D., Fox N. L., Roth D. & Gordon D. (20190722). Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus. : Arthritis & rheumatology (Hoboken, N.J.).

Chicago

Doria A, Stohl W, Schwarting A, Okada M, Scheinberg M, van Vollenhoven R, Hammer A E, Groark J, Bass D, Fox N L, Roth D and Gordon D. 20190722. Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus. : Arthritis & rheumatology (Hoboken, N.J.).

Harvard

Doria A., Stohl W., Schwarting A., Okada M., Scheinberg M., van Vollenhoven R., Hammer A. E., Groark J., Bass D., Fox N. L., Roth D. and Gordon D. (20190722). Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus. : Arthritis & rheumatology (Hoboken, N.J.).

MLA

Doria A, Stohl W, Schwarting A, Okada M, Scheinberg M, van Vollenhoven R, Hammer A E, Groark J, Bass D, Fox N L, Roth D and Gordon D. Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus. : Arthritis & rheumatology (Hoboken, N.J.). 20190722.